How do minor oral surgery courses impact the confidence levels of general dental practitioners?

Introduction There is set to be a change in the way that oral surgery will be delivered with the introduction of managed clinical networks. The changes may require general dental practitioners (GDPs) to carry out more minor oral surgery in primary care.Aim To determine the effectiveness of courses on GDPs carrying minor oral surgery in primary care.

Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review.

The link between medication-related osteonecrosis of the jaw (MRONJ) and bone modulating drugs, such as bisphosphonates and denosumab, is well established, and the number of reported cases is increasing. The development of novel medications used in the treatment of cancer, as well as autoimmune and bone conditions, has led to more cases of MRONJ being reported. However, in addition to this group of medications, increasing numbers of new agents in cancer therapy, such as antiangiogenic agents, have also been implicated in the development of MRONJ.

Axitinib-related osteonecrosis of the jaw.

Tyrosine kinase inhibitors (TKIs) are oral chemotherapy drugs used primarily to treat leukemias, renal cell carcinomas, gastrointestinal stromal tumors, and neuroendocrine tumors. Within this group, a number of drugs have already been implicated in jaw necrosis. Axitinib (Inlyta) is a novel TKI currently licensed for the treatment of renal cell carcinoma.